Document is current
Any future updates will be listed below
-
Authors
Wong, William W. L. https://orcid.org/0000-0003-4630-0052
Pechivanoglou, Petros
Wong, Josephine
Bielecki, Joanna M.
Haines, Alex
Erman, Aysegul
Saeed, Yasmin
Phoon, Arcturus
Tadrous, Mina
Younis, Mona
Rayad, Noha Z.
Rac, Valeria
Janssen, Harry L. A.
Krahn, Murray D.
-
Funding
Funding for this research was provided by:
Ontario Drug Policy Research Network
Ontario Ministry of Research, Innovation, and Science Early Researcher Award
- License Information
-
More Information
Article History
Received: 14 December 2018
Accepted: 4 August 2019
First Online: 19 August 2019
Competing interests
: William Wong and Murray Krahn have received research support from the Canadian Liver Foundation. Harry L. A. Janssen received grants from AbbVie, Bristol Myers Squibb, Gilead Sciences, Innogenetics, Janssen, Medimmune, Medtronic, Merck, and Roche and is consultant for AbbVie, Benitec, Bristol Myers Squibb, Gilead Sciences, Janssen, Medimmune, Merck, Roche and Arbutus. None of the other co-authors has any conflict of interest to declare.
